I was a little late to the party in buying Guardant Health (NASDAQ:GH). After watching the stock soar during the latter part of 2018 and the first half of 2019, I finally jumped in to scoop up shares in July of last year. I’m glad I did.
But do I regret missing out on investing in Guardant Health at its initial public offering (IPO)? Yep. If you didn’t get in on the IPO, you might already share the same regret (at the very least, you soon will). Here’s how much you’d have today if you had invested $10,000 in Guardant Health’s IPO.
A huge winner
Some IPO stocks rise quickly but then the gains evaporate. Not Guardant Health. It’s been a huge winner since day one.
Guardant Health operated as a privately held company for roughly six years before listing its shares on the Nasdaq